Logo image of HITI

HIGH TIDE INC (HITI) Stock Fundamental Analysis

USA - NASDAQ:HITI - CA42981E4013 - Common Stock

2.71 USD
0 (0%)
Last: 11/20/2025, 9:31:09 AM
Fundamental Rating

4

Overall HITI gets a fundamental rating of 4 out of 10. We evaluated HITI against 192 industry peers in the Pharmaceuticals industry. HITI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. HITI is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

HITI had negative earnings in the past year.
In the past year HITI had a positive cash flow from operations.
HITI had negative earnings in each of the past 5 years.
Of the past 5 years HITI 4 years had a positive operating cash flow.
HITI Yearly Net Income VS EBIT VS OCF VS FCFHITI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M

1.2 Ratios

With a decent Return On Assets value of -3.76%, HITI is doing good in the industry, outperforming 73.44% of the companies in the same industry.
HITI has a Return On Equity of -6.93%. This is in the better half of the industry: HITI outperforms 76.04% of its industry peers.
HITI's Return On Invested Capital of 5.06% is amongst the best of the industry. HITI outperforms 83.33% of its industry peers.
Industry RankSector Rank
ROA -3.76%
ROE -6.93%
ROIC 5.06%
ROA(3y)-14.91%
ROA(5y)-13.84%
ROE(3y)-26.27%
ROE(5y)-34.31%
ROIC(3y)N/A
ROIC(5y)N/A
HITI Yearly ROA, ROE, ROICHITI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200 -250

1.3 Margins

With a decent Operating Margin value of 2.30%, HITI is doing good in the industry, outperforming 78.65% of the companies in the same industry.
Looking at the Gross Margin, with a value of 25.83%, HITI is in line with its industry, outperforming 54.17% of the companies in the same industry.
HITI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.3%
PM (TTM) N/A
GM 25.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.25%
GM growth 5Y-5.48%
HITI Yearly Profit, Operating, Gross MarginsHITI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60 -80

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HITI is destroying value.
The number of shares outstanding for HITI has been increased compared to 1 year ago.
HITI has more shares outstanding than it did 5 years ago.
HITI has a better debt/assets ratio than last year.
HITI Yearly Shares OutstandingHITI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
HITI Yearly Total Debt VS Total AssetsHITI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 3.11 indicates that HITI is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.11, HITI is doing good in the industry, outperforming 69.27% of the companies in the same industry.
The Debt to FCF ratio of HITI is 4.08, which is a neutral value as it means it would take HITI, 4.08 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.08, HITI belongs to the top of the industry, outperforming 84.38% of the companies in the same industry.
A Debt/Equity ratio of 0.43 indicates that HITI is not too dependend on debt financing.
HITI has a worse Debt to Equity ratio (0.43) than 60.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 4.08
Altman-Z 3.11
ROIC/WACC0.64
WACC7.86%
HITI Yearly LT Debt VS Equity VS FCFHITI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.85 indicates that HITI should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.85, HITI is doing worse than 64.06% of the companies in the same industry.
A Quick Ratio of 1.29 indicates that HITI should not have too much problems paying its short term obligations.
The Quick ratio of HITI (1.29) is worse than 69.79% of its industry peers.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.29
HITI Yearly Current Assets VS Current LiabilitesHITI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

6

3. Growth

3.1 Past

HITI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -328.07%.
The Revenue has grown by 11.18% in the past year. This is quite good.
Measured over the past years, HITI shows a very strong growth in Revenue. The Revenue has been growing by 75.59% on average per year.
EPS 1Y (TTM)-328.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)11.18%
Revenue growth 3Y42.34%
Revenue growth 5Y75.59%
Sales Q2Q%13.67%

3.2 Future

The Earnings Per Share is expected to grow by 74.44% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 15.68% on average over the next years. This is quite good.
EPS Next Y3.81%
EPS Next 2Y103.67%
EPS Next 3Y96.71%
EPS Next 5Y74.44%
Revenue Next Year13.63%
Revenue Next 2Y21.39%
Revenue Next 3Y17.79%
Revenue Next 5Y15.68%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
HITI Yearly Revenue VS EstimatesHITI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M 1B
HITI Yearly EPS VS EstimatesHITI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 -1

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HITI. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 28.06, HITI can be considered very expensive at the moment.
73.44% of the companies in the same industry are more expensive than HITI, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of HITI to the average of the S&P500 Index (35.42), we can say HITI is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 28.06
HITI Price Earnings VS Forward Price EarningsHITI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

89.06% of the companies in the same industry are more expensive than HITI, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HITI indicates a rather cheap valuation: HITI is cheaper than 84.38% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 16.81
EV/EBITDA 9.59
HITI Per share dataHITI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HITI does not grow enough to justify the current Price/Earnings ratio.
HITI's earnings are expected to grow with 96.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y103.67%
EPS Next 3Y96.71%

0

5. Dividend

5.1 Amount

HITI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HIGH TIDE INC

NASDAQ:HITI (11/20/2025, 9:31:09 AM)

2.71

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)09-15 2025-09-15/amc
Earnings (Next)01-27 2026-01-27/amc
Inst Owners6.97%
Inst Owner Change161.72%
Ins Owners8.32%
Ins Owner ChangeN/A
Market Cap236.39M
Revenue(TTM)568.25M
Net Income(TTM)-9.80M
Analysts80
Price Target5.27 (94.46%)
Short Float %5.16%
Short Ratio5.17
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)194.66%
Min EPS beat(2)-8%
Max EPS beat(2)397.33%
EPS beat(4)1
Avg EPS beat(4)15.55%
Min EPS beat(4)-315.76%
Max EPS beat(4)397.33%
EPS beat(8)5
Avg EPS beat(8)75.15%
EPS beat(12)9
Avg EPS beat(12)61.94%
EPS beat(16)12
Avg EPS beat(16)45.88%
Revenue beat(2)1
Avg Revenue beat(2)-0.2%
Min Revenue beat(2)-1.49%
Max Revenue beat(2)1.09%
Revenue beat(4)3
Avg Revenue beat(4)0.59%
Min Revenue beat(4)-1.49%
Max Revenue beat(4)1.6%
Revenue beat(8)5
Avg Revenue beat(8)0.02%
Revenue beat(12)9
Avg Revenue beat(12)1.49%
Revenue beat(16)13
Avg Revenue beat(16)7.4%
PT rev (1m)1.01%
PT rev (3m)-5.98%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)14.29%
EPS NY rev (3m)-9.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)6.53%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)2.23%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 28.06
P/S 0.58
P/FCF 16.81
P/OCF 11.33
P/B 2.34
P/tB 6.38
EV/EBITDA 9.59
EPS(TTM)-0.09
EYN/A
EPS(NY)0.1
Fwd EY3.56%
FCF(TTM)0.16
FCFY5.95%
OCF(TTM)0.24
OCFY8.83%
SpS4.65
BVpS1.16
TBVpS0.42
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.76%
ROE -6.93%
ROCE 6.4%
ROIC 5.06%
ROICexc 7.36%
ROICexgc 20.27%
OM 2.3%
PM (TTM) N/A
GM 25.83%
FCFM 3.47%
ROA(3y)-14.91%
ROA(5y)-13.84%
ROE(3y)-26.27%
ROE(5y)-34.31%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.25%
GM growth 5Y-5.48%
F-Score5
Asset Turnover2.18
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 4.08
Debt/EBITDA 1.67
Cap/Depr 41.17%
Cap/Sales 1.68%
Interest Coverage 250
Cash Conversion 80.65%
Profit Quality N/A
Current Ratio 1.85
Quick Ratio 1.29
Altman-Z 3.11
F-Score5
WACC7.86%
ROIC/WACC0.64
Cap/Depr(3y)28.99%
Cap/Depr(5y)34.63%
Cap/Sales(3y)1.88%
Cap/Sales(5y)2.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-328.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y3.81%
EPS Next 2Y103.67%
EPS Next 3Y96.71%
EPS Next 5Y74.44%
Revenue 1Y (TTM)11.18%
Revenue growth 3Y42.34%
Revenue growth 5Y75.59%
Sales Q2Q%13.67%
Revenue Next Year13.63%
Revenue Next 2Y21.39%
Revenue Next 3Y17.79%
Revenue Next 5Y15.68%
EBIT growth 1Y2.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year418.19%
EBIT Next 3Y133.23%
EBIT Next 5Y81.34%
FCF growth 1Y38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.53%
OCF growth 3YN/A
OCF growth 5YN/A

HIGH TIDE INC / HITI FAQ

What is the fundamental rating for HITI stock?

ChartMill assigns a fundamental rating of 4 / 10 to HITI.


What is the valuation status of HIGH TIDE INC (HITI) stock?

ChartMill assigns a valuation rating of 4 / 10 to HIGH TIDE INC (HITI). This can be considered as Fairly Valued.


Can you provide the profitability details for HIGH TIDE INC?

HIGH TIDE INC (HITI) has a profitability rating of 3 / 10.


What is the financial health of HIGH TIDE INC (HITI) stock?

The financial health rating of HIGH TIDE INC (HITI) is 5 / 10.


Can you provide the expected EPS growth for HITI stock?

The Earnings per Share (EPS) of HIGH TIDE INC (HITI) is expected to grow by 3.81% in the next year.